CJC-1295 (no DAC) + Ipamorelin (CI10)

Description

Overview

CJC-1295 (no DAC) + Ipamorelin is a dual-peptide formulation developed for laboratory studies focusing on peptide synergy, signaling pathways, and controlled-response experiments. The absence of DAC ensures shorter activity duration, making it ideal for precise research timing.

Key Features

• Dual-peptide synergistic blend
• Short-acting activity profile
• High purity lyophilized formulation
• Designed for controlled experimental use

Research Applications

• Peptide synergy studies
• Cellular signaling research
• Controlled response experiments
• Hormonal pathway analysis

Product Specifications

• Form: Lyophilized powder
• Compound: CJC-1295 (no DAC) + Ipamorelin
• Blend Ratio: 5mg / 5mg
• Purity: ≥98% (each component, typical)
• Storage: Store at -20°C

Reconstitution

Reconstitute using bacteriostatic water under sterile laboratory conditions. Follow standard research handling procedures.

Disclaimer

For research use only. Not for human consumption, medical, or therapeutic purposes.